Edge Pharma, LLC recalls Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856
Recalled February 2, 2022 · FDA recall D-0444-2022 · Edge Pharma
Hazard
CGMP Deviations · FDA Class II
Units
231 bottles
Sold at
nationwide
Description
CGMP Deviations
Product
Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1045-03
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →